MENU
ALNY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Alnylam Pharmaceuticals (ALNY) Earnings Date & Reports

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

ALNY is expected to report earnings to fall 55.17% to $1.30 per share on February 12

Alnylam Pharmaceuticals ALNY Stock Earnings Reports
Q4'25
Est.
$1.30
Q3'25
Beat
by $2.38
Q2'25
Beat
by $0.91
Q1'25
Beat
by $0.92
Q4'24
Beat
by $0.64
The last earnings report on October 30 showed earnings per share of $2.90, beating the estimate of 51 cents. With 798.91K shares outstanding, the current market capitalization sits at 59.98B.
View a ticker or compare two or three
ALNY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ALNY showed earnings on October 30, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of therapeutics based on RNA interference

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
675 West Kendall Street
Phone
+1 617 551-8200
Employees
2100
Web
https://www.alnylam.com